The UK’s proposed regulations would provide the legal framework for POC manufact...
Johnson & Johnson Innovation Medicine has submitted a request to the FDA to appr...
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supp...
Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J...
TCR immunotherapy is emerging as a promising, targeted approach for treating sol...
The biotech uses its AI platform to discover the therapeutic potential of plant-...
Incyte faced severe difficulties just a few months after purchasing Escient Phar...
The Canada-based biotechnology company Cybin has announced the results of a Phas...
Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialis...
UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragme...
The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 ...
Tris Pharma has received additional ex-US approvals for its ADHD treatments, Qui...
Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scient...
Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in ...
The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathw...
Discover leading sales enablement and marketing intelligence solutions tailored ...
